Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,808 | Dovepress* | 11,159+ | 1,155 | 12,314 | |
PubMed Central* | 649 | 148 | 797 | ||
Totals | 11,808 | 1,303 | 13,111 | ||
*Since 21 August 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar